ResMed (RMD) Tops Q1 EPS by 15c

ResMed (NYSE: RMD) reported Q1 EPS of $1.51, $0.15 better than the analyst estimate of $1.36. Revenue for the quarter came in at $904 million versus the consensus estimate of $860.89 million.

For earnings history and earnings-related data on ResMed (RMD) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does
• Benchmark Reiterates Buy Rating on H World Group Ltd. (HTHT) Following Q2 Print